Precision BioSciences (NASDAQ:DTIL) reported Q1 EPS of ($0.46), $0.09 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $3.32 million versus the consensus estimate of $6.63 million.
Precision BioSciences (NASDAQ:DTIL) reported Q1 EPS of ($0.46), $0.09 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $3.32 million versus the consensus estimate of $6.63 million.